Skip to main content
. 2020 Sep 17;22(9):e16053. doi: 10.2196/16053

Figure 3.

Figure 3

Sensitivity analysis of the incremental cost-effectiveness ratio (ICER) using utility values. CVD: cardiovascular disease; ESRD: end-stage renal disease; QALY: quality-adjusted life year.